Bcl-2 and apoptosis in chronic lymphocytic leukemia.

@article{Schimmer2003Bcl2AA,
  title={Bcl-2 and apoptosis in chronic lymphocytic leukemia.},
  author={Aaron David Schimmer and Irene Munk-Pedersen and Mark D Minden and John C. Reed},
  journal={Current treatment options in oncology},
  year={2003},
  volume={4 3},
  pages={211-8}
}
The Bcl-2 family of pro- and antiapoptotic proteins are key regulators of the apoptosis cascade and the mitochondrial-mediated pathway of caspase activation. Of this family, Bcl-2 was the first identified and remains the best characterized. Aberrant expression of Bcl-2 is common in chronic lymphocytic leukemia (CLL) and is associated with poor response to chemotherapy and decreased overall survival. Bcl-2 is an attractive target for novel therapeutic agents. Antisense oligonucleotides directed… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 34 extracted citations

Similar Papers

Loading similar papers…